# PGL4001 Versus GnRH-agonist in Uterine Myomas

> **NCT00740831** · PHASE3 · COMPLETED · sponsor: **PregLem SA** · enrollment: 301 (actual)

## Conditions studied

- Uterine Myomas

## Interventions

- **DRUG:** PGL4001
- **DRUG:** leuprorelin

## Key facts

- **NCT ID:** NCT00740831
- **Lead sponsor:** PregLem SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-06
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2012-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00740831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00740831, "PGL4001 Versus GnRH-agonist in Uterine Myomas". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00740831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*